Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study-Reference-Cited by-同舟云学术

Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study

Published:2023-10 Issue: Volume: Page:
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Vokes Everett E.,Mornex Francoise,Sezer Ahmet,Cheng Ying,Fang Jian,Baz David Vicente,Cil Timucin,Adjei Alex A.,Ahn Myung-Ju,Barlesi Fabrice,Felip Enriqueta,Garon Edward B.,Audhuy Francois,Ito Rena,Sato Masashi,Eggleton S. Peter,Martin Claudio Marcelo,Reck Martin,Robinson Clifford G.,Paz-Ares Luis

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference34 articles.

1. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

2. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer;Goldstraw;J Thorac Oncol,2016

3. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Antonia;N Engl J Med,2017

4. Four-year survival with durvalumab after chemoradiotherapy in stage III NSCLC-an update from the PACIFIC trial;Faivre-Finn;J Thorac Oncol,2021

5. Treatment characteristics and real-world progression-free survival in patients with unresectable stage III NSCLC who received durvalumab after chemoradiotherapy: findings from the PACIFIC-R study;Girard;J Thorac Oncol,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism;OncoImmunology;2024-07-09